Astragaloside IV mitigates myocardial ischemia/reperfusion injury by modulating the 14-3-3η/GPX4 axis, reducing

Rui-Yuan Zeng1, Zhi-Cong Qiu1, Shi-Tao Zhao1

  • 1Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China; Institute of Cardiovascular Surgical Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.

Abstract

Insights

Astragaloside IV protects against myocardial ischemia/reperfusion injury (MIRI) by reducing ferroptosis, apoptosis, and mitochondrial dysfunction. It modulates the 14-3-3η/GPX4 axis, preserving cardiac tissue function.

Area of Science:

  • Cardiology
  • Biochemistry
  • Cell Biology

Background:

  • Myocardial ischemia/reperfusion injury (MIRI) is a significant complication of acute myocardial infarction (AMI).
  • Ferroptosis, apoptosis, and mitochondrial dysfunction are key pathological processes in MIRI.
  • The protective mechanisms of Astragaloside IV (Ast) against MIRI are not fully understood.

Purpose of the Study:

  • To investigate the protective effects of Astragaloside IV (Ast) against myocardial ischemia/reperfusion injury (MIRI).
  • To elucidate the underlying molecular mechanisms of Ast's cardioprotective action in MIRI.

Main Methods:

  • Utilized H9c2 cell anoxia/reoxygenation and Sprague-Dawley rat MIRI models.
  • Assessed cardiac injury, oxidative stress, apoptosis, ferroptosis, and mitochondrial function using various assays.
  • Investigated the expression, localization, and interaction of 14-3-3η and GPX4 via Western blotting, confocal microscopy, and Co-IP.

Main Results:

  • Ast pretreatment significantly improved cardiac function and reduced infarct size in MIRI models.
  • Ast attenuated ferroptosis, apoptosis, and oxidative stress, while preserving mitochondrial function.
  • Ast upregulated 14-3-3η, enhancing its interaction with GPX4 and stabilizing GPX4 through modulating ubiquitination.

Conclusions:

  • Astragaloside IV ameliorates MIRI by mitigating ferroptosis, apoptosis, and mitochondrial dysfunction.
  • The protective effects of Ast are mediated through the modulation of the 14-3-3η/GPX4 axis.
  • Ast demonstrates significant cardioprotective potential against myocardial ischemia/reperfusion injury.

Related Concept Videos